# Bacteriophage Therapy in Spinal Cord Injury Patients With Bacteriuria

> **NCT06559618** · PHASE1 · RECRUITING · sponsor: **Barbara Trautner** · enrollment: 30 (estimated)

## Conditions studied

- Bacteriuria
- Spinal Cord Injuries
- Asymptomatic Bacteriuria
- Escherichia Coli

## Interventions

- **DRUG:** Phage Therapy
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06559618
- **Lead sponsor:** Barbara Trautner
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-03
- **Primary completion:** 2027-09
- **Final completion:** 2028-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06559618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06559618, "Bacteriophage Therapy in Spinal Cord Injury Patients With Bacteriuria". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06559618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*